Nonalcoholic steatohepatitis (NASH) is a massive public health challenge; Sino Biological is currently producing a huge range of NASH related drug targets and reagents.
Researchers examined the pathological impacts of the structural components of SARS-CoV-2 on human periodontal cells and tissue to understand the association between coronavirus disease 2019 (COVID-19) and deteriorating oral health.
The interleukin-4 receptor (IL-4R) is emerging as a potential drug target, projected to potentially be worth up to 10 billion USD. In this article, ACROBiosystems discusses why it is such an attractive drug target and what this could entail.